Intensity Therapeutics Inc (INTS): Next-Year EPS Estimate 39.54%
As of 2026-11-12, Intensity Therapeutics Inc (INTS) has a next-year EPS growth estimate of 39.54%. Featured in our EPS revision report on 2026-08-20.
On 2026-11-11, analyst consensus for INTS's next-year EPS growth shifted from 41.33% to 39.54% — a negative change of 1.79 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 50.63%.
What's Driving This
INTS has been rising primarily because its next-year EPS estimate has been revised upward consistently across three trading sessions, with a net increase of 6.17 percentage points and a current next-year EPS growth estimate of 41.33%. No recent news headlines are available to identify a specific earnings beat, contract win, guidance raise, or product launch as the catalyst. The multi-session estimate revision indicates momentum has continued beyond an initial change, though no headline clearly explains the move.
Generated 2026-11-11 from news as of 2026-11-10
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 39.54%
- EPS growth this year
- 50.63%
- EPS next quarter (est)
- -$1.06
- Last price
- $3.08
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 39.54% | 50.63% | -$1.06 | $3.08 |
| 2026-11-11 | 39.54% | 50.63% | -$1.06 | $3.28 |
| 2026-11-10 | 41.33% | 52.36% | -$1.00 | $3.09 |
| 2026-11-09 | 39.81% | 52.69% | -$0.99 | $3.15 |
| 2026-11-07 | 39.81% | 52.69% | -$0.99 | $3.00 |
| 2026-11-06 | 39.81% | 52.69% | -$0.99 | $3.00 |
| 2026-11-05 | 36.26% | 58.76% | -$0.78 | $3.10 |
| 2026-11-04 | 35.16% | 59.46% | -$0.99 | $3.50 |
| 2026-11-03 | 35.16% | 59.46% | -$0.99 | $3.38 |
| 2026-11-02 | 35.16% | 59.46% | -$0.99 | $3.43 |
| 2026-10-31 | 35.16% | 59.46% | -$0.99 | $3.40 |
| 2026-10-30 | 35.16% | 59.46% | -$0.99 | $3.40 |
| 2026-10-29 | 35.16% | 59.46% | -$0.99 | $3.34 |
| 2026-10-28 | 35.16% | 59.46% | -$0.99 | $3.38 |
| 2026-10-27 | 35.16% | 59.46% | -$0.99 | $3.18 |
| 2026-10-26 | 35.16% | 59.46% | -$0.99 | $3.20 |
| 2026-10-23 | 35.16% | 59.46% | -$0.99 | $3.25 |
| 2026-10-22 | 35.16% | 59.46% | -$0.99 | $3.19 |
| 2026-10-21 | 35.16% | 59.46% | -$0.99 | $3.14 |
| 2026-10-20 | 35.16% | 59.46% | -$0.99 | $3.28 |
| 2026-10-19 | 35.16% | 59.46% | -$0.99 | $3.29 |
| 2026-10-16 | 35.16% | 59.46% | -$0.99 | $3.35 |
| 2026-10-15 | 35.16% | 59.46% | -$0.99 | $3.38 |
| 2026-10-14 | 35.16% | 59.46% | -$0.99 | $3.42 |
| 2026-10-13 | 35.16% | 59.46% | -$0.99 | $3.55 |
| 2026-10-12 | 35.16% | 59.46% | -$0.99 | $3.31 |
| 2026-10-11 | 35.16% | 59.46% | -$0.99 | $3.63 |
| 2026-10-10 | 35.16% | 59.46% | -$0.99 | $3.63 |
| 2026-10-09 | 35.16% | 59.46% | -$0.99 | $3.63 |
| 2026-10-08 | 35.16% | 59.46% | -$0.99 | $3.68 |
Reports Featuring INTS
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Intensity Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Intensity Therapeutics Inc (INTS) has a next-year EPS growth estimate of 39.54%, based on analyst consensus.
When was the latest EPS estimate revision for INTS?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 41.33% to 39.54%.
What sector and industry does Intensity Therapeutics Inc belong to?▾
Intensity Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INTS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Intensity Therapeutics Inc (INTS) appears here because it was detected by our daily top-EPS-revision-performer screen.